Glaucoma Research Foundation Appoints Candler Gibson Director Of Development

Main Category: Eye Health / Blindness
Article Date: 18 Jun 2009 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

The Glaucoma Research Foundation is pleased to announce the addition of Candler Gibson as the organization's new Director of Development. Mr. Gibson brings nearly 20 years of experience in development and fundraising, most recently as Director of Development for the Johns Hopkins Heart and Vascular Institute in Baltimore.

"We are delighted that Candler has joined the Glaucoma Research Foundation to direct the continued growth of our fundraising activities and make the critical research we fund possible," said Thomas Brunner, the foundation's Chief Executive Officer.

Mr. Gibson has been involved in development and fundraising at major academic medical institutions including the University of California, San Francisco and Yale where he actively raised funds for the $285 million Campaign for the Yale School of Medicine.

Mr. Gibson is a graduate of Yale University in New Haven, CT, where he was active in music and literary clubs. He began his Development career at Yale.

About the Glaucoma Research Foundation

Founded in 1978, the mission of the Glaucoma Research Foundation is to prevent vision loss from glaucoma through investment in innovative research, education, and patient support - all directed toward the ultimate goal of finding a cure.

In the three decades that have followed, more than $45 million of grants and projects have been funded by GRF. In addition to attracting innovative scientists, doctors and ideas to the field of glaucoma research, GRF has also provided education and support for those with glaucoma, as well as to their families and friends.

All of these grants have been raised without the benefit of government funding. In fact, GRF is almost entirely supported through donations from private individuals. Equally important, 85 cents of every dollar raised goes directly to funding innovative research and education programs.

The primary focus of GRF-funded research is the Catalyst For a Cure (CFC). This collaborative project is redefining how glaucoma research is conducted by accelerating the process of discovery to find a cure. The CFC research scientists .- specialists in genetics, nerve regeneration, and neurodevelopment - are working in real-time collaboration to understand neuronal loss in glaucoma and identify targets for intervention.

For More Information

The Glaucoma Research Foundation website, http://www.glaucoma.org, has a wide range of information and news for glaucoma patients and their families. Free educational brochures and an informative booklet, "Understanding and Living with Glaucoma," may be ordered from the website or by calling GRF at 1-800-826-6693. An experienced information specialist answers the phone to provide support and assistance to those with questions or concerns. The foundation's free newsletter, Gleams, provides the latest information about glaucoma treatments and research.

Source
Glaucoma Research Foundation